03:39 PM EDT, 07/02/2024 (MT Newswires) -- Health care stocks were softer late Tuesday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.4%.

The iShares Biotechnology ETF (IBB) fell 0.7%.

In corporate news, Eli Lilly ( LLY ) said Tuesday the US Food and Drug Administration approved Kisunla for the treatment of adults with early symptomatic Alzheimer's disease. Its shares were shedding 0.7%.